National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents. [electronic resource]
Producer: 20080828Description: 209-17 p. digitalISSN:- 1097-6787
- Adalimumab
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Arthritis, Psoriatic -- drug therapy
- Decision Trees
- Drug Administration Schedule
- Etanercept
- Humans
- Immunoglobulin G -- administration & dosage
- Immunologic Factors -- administration & dosage
- Infliximab
- Mass Screening -- methods
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Societies, Medical
- Tuberculin Test
- Tuberculosis -- chemically induced
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- United States
No physical items for this record
Publication Type: Consensus Development Conference; Journal Article; Practice Guideline
There are no comments on this title.
Log in to your account to post a comment.